Saad Nseir
Elite in Tracheitis

Saad Nseir

Lille, FR 
Elite in Tracheitis
Lille, FR 
OverviewLocationsClinical Research

Overview

Saad Nseir practices in Lille, France. Mr. Nseir is rated as an Elite expert by MediFind in the treatment of Tracheitis. His top areas of expertise are Pneumonia, Tracheitis, Hospital-Acquired Pneumonia, and Bronchitis.

His clinical research consists of co-authoring 257 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Tracheitis.

Gender
Male

Locations

Lille, France
Other Locations
135 Rue Du Président Coty, Tourcoing, 59200, France
Poitiers, France
Bordeaux, France
Orleans, France
Amiens, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Analysis of TLRs and Lectin Gene Polymorphisms. Impact on Yeast Colonization in Hospitalized Patients and on Adaptive Response Against Yeast Glycans
Analysis of TLRs and Lectin Gene Polymorphisms. Impact on Yeast Colonization in Hospitalized Patients and on Adaptive Response Against Yeast Glycans
Enrollment Status: Completed
Publish Date: November 04, 2022
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Cardiac Arrest Incidence and Outcome Among Patient With COVID-19 Pneumonia in French ICUs
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Other
Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
Enrollment Status: Completed
Publish Date: October 05, 2022
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
A Phase Ib/IIa, Randomised, Double Blind, Parallel Group, Placebo Controlled, Multicentre Study to Assess the Safety and Efficacy of Expanded Cx611 Allogeneic Adipose-derived Stem Cells (eASCs) for the Intravenous Treatment of Adult Patients With Severe Community-acquired Bacterial Pneumonia and Admitted to the Intensive Care Unit
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Biological, Other
Study Drug: Cx611
Study Phase: Phase 1/Phase 2
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Phase 3 Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Reltecimod as Compared to Placebo in Addition to Standard of Care in Patients With Sepsis-associated Acute Kidney Injury (SA-AKI)
Enrollment Status: Terminated
Publish Date: October 12, 2021
Intervention Type: Drug
Study Phase: Phase 3
Impact of SARS-CoV-2 Infection on the Incidence of Ventilator-acquired Infections
Impact of SARS-CoV-2 Infection on the Incidence of Ventilator-acquired Infections
Enrollment Status: Completed
Publish Date: July 22, 2020
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
Enrollment Status: Terminated
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study
Enrollment Status: Completed
Publish Date: March 27, 2017
Intervention Type: Other
Study Phase: Not Applicable
View 7 Less Clinical Trials

256 Total Publications

Outcomes of Critically Ill Adult Patients With Acute Encephalitis.
Outcomes of Critically Ill Adult Patients With Acute Encephalitis.
Journal: JAMA network open
Published: September 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nseir's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile